Let Your Voice Be Heard at Digital RESI JPM

November 18, 2021 ~ Next Phase Admin ~ Leave a comment

By Rory McCann, Marketing Manager & Conference Producer, LSN

As Digital RESI November closes today, the team at Life Science Nation is looking ahead to Digital RESI JPM, January 11-13, 2022. In addition to RESI’s powerful partnering system, the virtual panels are a highlight for investors and fundraising entrepreneurs alike. RESI panels feature industry innovators and subject matter experts to discuss navigating the early-stage ecosystem within life science and healthcare, tackling topics relevant to fundraising and company-building.

Is there a topic you’d like to see at Digital RESI JPM? Would you recommend a particular industry expert or prolific investor to speak to fundraising in this space? We want to hear from you and highlight the issues and stories that are most meaningful to the RESI community. Send your suggestions to RESI@lifesciencenation.com and sign up for Digital RESI JPM by Friday, November 28 to save $300!

Digital RESI JPM Pitch Applications Open

November 18, 2021November 18, 2021 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Today is the last day of the Digital RESI November Innovator’s Pitch Challenge. If you missed your opportunity to pitch to relevant investors seeking opportunities in your space, Digital RESI JPM, January 11-13, 2022 is right around the corner! Join us at the biggest virtual fundraising event of the year and submit your application the the Digital RESI JPM Innovator’s Pitch Challenge.

What is it?

The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Participating companies pay registration and a $800 pitching fee to host their company materials on the Live Agenda and participate in the live pitch session.

How Does it Work?

Pitching companies will have a dedicated webpage on the Live Agenda, which greatly increases visibility to investors. Prior to the live pitch session, the investor panel will review submitted pitch materials and prepare questions.

Each company has approximately 10 minutes set aside for their participation. Each session is judged by a panel of investors who have expressed interest in the sector(s) highlighted in the session. During the session, the pitching company delivers a brief (~1 minute) elevator pitch, and saves the rest of their time for investors’ questions, feedback and commentary. The session is open to all registered RESI attendees.

Who Should Apply?

Early-stage life science companies actively raising seed capital (25K-2MM), Series A (2MM-10MM), or Series B (10MM-50MM) use the IPC to get in front of the panel of qualified investor judges in their market segment and pitch their company and product. Early-stage companies are encouraged to submit an application, along with a pitch deck and an executive summary. Once selected to pitch, companies can submit their video and supplemental materials for investors to review prior to the live session.

Digital RESI November at a Glance

November 18, 2021November 18, 2021 ~ Next Phase Admin ~ Leave a comment

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Digital RESI November is not over yet but has so far been one of our most successful virtual events. With over 600 attendees from 30 countries across 5 continents, RESI continues to demonstrate how truly global Life Science Nation (LSN)’s early-stage ecosystem is. Attendees have had access to investor panels, workshops and could watch over 50 presenting companies in the Innovator’s Pitch Challenge. With two days down and one day left, over 1,000 meetings have already taken place through RESI’s unique, match-based partnering platform. With our next RESI, taking place during JP Morgan Healthcare Week, right around the corner, make sure not to miss out on the next opportunity to take part in a virtual event that truly works! Sign up by November 28 to save $300!

Digital RESI at JPM

November 11, 2021November 11, 2021 ~ Next Phase Admin ~ Leave a comment

By Candice He, Vice President of Business Development, Global Investment Strategist, LSN

Digital Redefining Early Stage Investment (RESI) returns to JP Morgan in its successful virtual format January 11-13, 2022! JPM Week is the World Series of early-stage life science and healthcare, bringing innovators, investors, and industry experts together to build relationships and make deals, which makes it a highly competitive event.

Digital RESI levels the playing field by offering quality content and compelling programs, like the Innovator’s Pitch Challenge, and match-based partnering fraction of the cost of the other partnering conferences.

	DIGITAL RESI @JPM	OTHER PARTNERING EVENTS (Virtual)
	DIGITAL RESI @JPM	@JPM	SPRING
Registration	$895	$1,795	€1,995
Registration + Pitch Fee	$1,695	$5,745	€2,240

*Prices as of today

The team at Life Science Nation understands the financial, logistical, and other non-tangible barriers to entry when it comes to early-stage fundraising. This is why Digital RESI is affordable, accessible, and designed to connect partnerships that are based on product fit and stage of development. To ensure founders are set up for optimal success, we also feature several complimentary fundraising bootcamps available to the public to introduce founders to our system, as well as provide resources and proven strategies to help them get started on the right foot!

Get to know your business development representative to learn what Digital RESI has to offer you on your unique fundraising journey and sign up for Digital RESI JPM, January 11-13 by November 28 to save $300 on super early bird rates.

Want to learn more? The Business Development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International	East Coast (USA) & China	Midwest (USA) & Canada	West Coast (USA)

Greg Mannix Vice President International Business Development Book a Meeting	Candice He Vice President of Business Development, Global Investment Strategist Book a Meeting	Antoinette Lowre Manager of Business Development Book a Meeting	Alexander Vassallo Manager of Business Development Book a Meeting

Digital RESI November Final Agenda

November 11, 2021 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

It’s been a busy week at Life Science Nation! As the audience chatters and orchestra buzzes in the moments before curtain opens on a show, the week before Digital RESI November 16-18 has been filled with booking meetings, partnering tutorials, panel planning calls, and putting the finishing touches on pitch materials. The energy is in the air and there’s nothing like it!

Check out some of the content coming to you virtually through Digital RESI November next week. Each session has been carefully crafted to highlight the best in early-stage life science and healthcare, and every feature is designed to connect fundraising founders with investors and strategic partners who are a fit for their product and stage of development.

	Tuesday (11/16)	Wednesday (11/17)	Thursday (11/18)
	All Day Partnering
10AM EST	Innovator’s Pitch Challenge #1 Diagnostics	First Republic Bank Workshop – How to Evaluate Your Banking Partner	Innovator’s Pitch Challenge #9 Longevity – Medical Devices
		Innovator’s Pitch Challenge #5 Oncology Therapeutics
11AM EST	Oncology Innovation Panel	Cognitive Care Panel	Digital Health Panel
	Innovator’s Pitch Challenge #2 Medical Devices		Innovator’s Pitch Challenge #10 Therapeutics
12PM EST	TriNet Workshop – Piecing Together the Talent Puzzle	MWE Workshop – Negotiating Term Sheets	Burns & Levinson Licensing Workshop
1PM EST	Innovator’s Pitch Challenge #3 R&D/Therapeutics	Innovator’s Pitch Challenge #6 AI – Drug Discovery	Innovator’s Pitch Challenge #11 Novel Drug Delivery
			Tales from the Road: AI Innovators on their Fundraising Journey
2PM EST	AI-Assisted Remote Care & Chronic Disease Management Panel	Investing in Precision Medicine Panel	Women in Age-Tech Panel
3PM EST	MedTech Strategics Panel	Clinical & Research Data Panel	Impact Investors Panel
4PM EST	Tales from the Road: Age-Tech Innovators on their Fundraising Journey	Tales from the Road: Biotech and MedTech Innovators on their Fundraising Journey
		Innovator’s Pitch Challenge #7 Longevity – Therapeutics & Digital Health
5PM EST	Angels & Family Offices Panel	Innovator’s Pitch Challenge #8 Medical Devices
	Innovator’s Pitch Challenge #4 AI – Medical Devices & Digital Health

If you haven’t yet signed up for Digital RESI November, sign up now! There is still time, but meeting slots are booking up fast. If you’re already looking ahead to 2022, sign up for Digital RESI JPM early to save on super early bird rates!

Embracing the Early-Stage Journey

November 11, 2021 ~ Next Phase Admin ~ Leave a comment

By Rory McCann, Marketing Manager & Conference Producer, LSN

David Dlesk is a seasoned entrepreneur and investor, passionate about therapeutic innovation, which has led him to co-found Embrace Prevention Care, a company dedicated to safe and effective medication adherence for older adults. David has decades of experience in early-stage life science and healthcare, and has learned how to lead, connect, and accept sound advice. Listen to our recent conversation and join David at Digital RESI November, where he’ll be featured on the Tales from the Road: Age-Tech Innovators on their Fundraising Journey panel on November 16 at 4 PM EST. If you’re an early-stage fundraising executive, there’s still time to sign up and book meetings!

Meet the RESI November Speakers

November 4, 2021November 4, 2021 ~ Next Phase Admin ~ Leave a comment

By Caitlin Dolegowski, Marketing Specialist, LSN

Imagine learning critical components to successful fundraising from key experts and deal-makers in a virtual environment specific to early-stage life science and healthcare. It seems too good to be true until you check out the Digital RESI November lineup. Digital RESI November 16-18 offers attendees three days of panels, workshops and pitch sessions, each of which is designed to enrich the journey of early-stage, life science entrepreneurs with insight into what investors are looking for, how CEOs have found success and learning from other fundraising executives. Panel topics have been created to cover hot industry topics, with panelist recruitment focused on adding valuable content for fundraising attendees. Check out the panelists that will be presenting at this November’s conference below.

Partnering has begun for this conference and there is still time to register to attend!


Sangeeta Agarawal Co-Founder & CEO Helpsy Health	Cynthia Cai Venture Partner Viva BioInnovator	Mylea Charvat Principal & Partner LiquidSMARTS	Jonathan Cohen CEO 20/20 GeneSystems

Ruchi Dana Board Member Dana Group	Nissim Darvish Senior Managing Director (Israel) OrbiMed Advisors LLC	Dave Dlesk CEO Embrace Prevention Care	Keren Etkin Founder TheGerontechnologist

Lana Feng Co-Founder & CEO HumaAI Inc	Dave Fogel Member of Screening & Due Diligence Committees Mass Medical Angels	Michael Fossel President and Founder Telocyte	Les Funtleyder Chief Investment Officer TechNik

Shruti Gandhi Founder & Managing Partner Array Ventures	Ernst Geutjes Partner Aglaia Oncology Funds	Tom Gibbs Director Debiopharm Innovation Fund	Kimberly Ha Founder & CEO KKH Advisors

André Harrell Venture Partner Cancer Fund	Chihiro Hosoya BD/VC Head, Rx+ Business Accelerator Astellas Rx+ Business Accelerator	Baudouin Hue Partner Karista	Rachel Stillman, MBA Senior Associate 7wire Ventures

Taha Jangda Partner HealthX Ventures	Yury Kukushkin Investment Director JDRF T1D Fund	Pepper Landson CEO Praetego Inc	Taja Lester Managing Partner Health Equity Capital

Justin Leushner Partner Launchit Ventures	Richard Lipkin Co-Founder, Co-Chair The Catalytic Impact Foundation	Betsabeh Madani Hermann, MBA Life Science and Healthcare Investor and Advisor	Andrew Meadow General Partner Health Innovation Capital

Andy Merken Partner, Corporate and Securities Co-Chair, Life Sciences Burns & Levinson	Brian Meshkin Managing Partner Profound Ventures	Petra Meyer Managing Director – HealthCare Sector Group Lead Golden Seeds	Christos Monovoukas VP, Global M&A/Business Development Olympus Corporation

Alex Morgan Partner Khosla Ventures	Sasha Naydich Associate Myeloma Investment Fund	Rohit Pratap Singh Vice President, Investments Xeraya Capital	Rachel Rea Director of Business Development and Licensing Medtronic

Christina Salys Director of New Business Development Intuitive Surgical	Beth Sanders Founder & CEO LifeBio Inc	Diana Saraceni Founder, Managing Director Panakes Partners	Rachel Scherl CEO SPARK Solutions for Growth

DJ (Dennis) Schmitt Founder/CEO Neuro20 Technologies	Bryan Shao K4 Deal Screening Committee Keiretsu Forum	Xuhui Shao Managing Partner Foothill Ventures	Patrik Sobocki Investment Manager Life Science Industrifonden

Thomas Vogelsong Investor/Life Science Advisor/Director, Deal Flow KYTO Technology and Life Science	Richard Ward Director, Search and Evaluation, Oncology R&D BD AstraZeneca	Travis Whitfill Partner Bios Partners	Thierry Wurch Senior Director Ipsen S.A.

	Tiffany Yu Vice President Equality Asset Management LP	Lu Zhang Managing Partner Fusion Fund